IGC Pharma
IGC
#10538
Rank
โ‚ฌ27.65 M
Marketcap
0,27ย โ‚ฌ
Share price
-7.16%
Change (1 day)
-27.26%
Change (1 year)
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities.

Revenue for IGC Pharma (IGC)

Revenue in 2026 (TTM): โ‚ฌ1.01 Million

According to IGC Pharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.02 Million. In 2025 the company made a revenue of โ‚ฌ1.02 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ1.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for IGC Pharma from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ1.01 M-0.77%
2025 โ‚ฌ1.02 M-14.07%
2024 โ‚ฌ1.18 M7.98%
2023 โ‚ฌ1.09 M35.94%
2022 โ‚ฌ0.8 M157.42%
2021 โ‚ฌ0.31 M-54.3%
2020 โ‚ฌ0.68 M-86.2%
2019 โ‚ฌ4.98 M20.94%
2018 โ‚ฌ4.12 M332.63%
2017 โ‚ฌ0.95 M-51.53%
2016 โ‚ฌ1.96 M-70.37%
2015 โ‚ฌ6.63 M48.85%
2014 โ‚ฌ4.45 M64.09%
2013 โ‚ฌ2.71 M-53.89%
2012 โ‚ฌ5.89 M104.64%
2011 โ‚ฌ2.87 M-46.79%
2010 โ‚ฌ5.41 M-54.58%
2009 โ‚ฌ11.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sterling Infrastructure
STRL
โ‚ฌ2.48 B 243,135.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
โ‚ฌ1.78 B 173,888.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
โ‚ฌ4.00 B 390,903.12%๐Ÿ‡บ๐Ÿ‡ธ USA